A decrease of mTOR and PAK4 protein expression was observed in HCC specimens from miRNA mimics treated animals, confirming similar mechanisms of action observed in other preclinical models, as well as in human HCCs [3,46]. This evidence concerns the gene MTOR and hepatocellular carcinoma.